FDA Adverse Event Injury Summary report: N

VITALITY 2

MDR report key: 3252021 · Received July 29, 2013

Report

Report Number
2124215-2013-11884
Event Type
Injury
Date Received
July 29, 2013
Date of Event
April 19, 2013
Report Date
April 19, 2013
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TN
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, A REVIEW OF DEVICE MEMORY REVEALED THAT THE DEVICE DECLARED ELECTIVE REPLACEMENT INDICATOR (ERI) AFTER EXPERIENCING TWO CONSECUTIVE CHARGE TIMES GREATER THAN THE EXTENDED MID-LIFE ERI CHARGE TIME LIMIT. THE OBSERVED RATE OF BATTERY USAGE WAS COMPARED TO THE EXPECTED RATE OF BATTERY USAGE; THE RESULTS INDICATED THAT THE MONITORING VOLTAGE WAS NORMAL. ALTHOUGH THE BATTERY ITSELF HAD NOT DEPLETED PREMATURELY, ERI WAS TRIGGERED EARLIER THAN EXPECTED BY EXTENDED CHARGE TIMES DUE TO A HIGHER-THAN-TYPICAL BUILDUP OF INTERNAL BATTERY IMPEDANCE.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) DEVICE TRIGGERED ELECTIVE REPLACEMENT INDICATOR (ERI) WITHIN WARRANTY PERIOD. THE PATIENT WAS NOT MONITORED AND THE DEVICE WAS PROGRAMMED AT ACUTE OUTPUTS SINCE IMPLANT. BOSTON SCIENTIFIC TECHNICAL SERVICES (TS) BELIEVED THE DEVICE REACHED ERI SOONER THAN EXPECTED BECAUSE OUTPUTS WERE SET HIGH LIKE THEY ARE FOR NEW IMPLANTS. THE DEVICE WAS EXPLANTED AND OUT OF SERVICE. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
352628 VITALITY 2 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND T167

Patients

Seq Age Sex Outcome Treatment
1 40 YR Hospitalization| L| R T167| E143| 4469| 0185